CVA Family Office’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55K Buy
24
+5
+26% +$742 ﹤0.01% 1300
2026
Q1
$1.77K Buy
+19
New +$1.68K ﹤0.01% 1554
2025
Q2
– Sell
-9
Closed -$447 – 1283
2025
Q1
$447 Buy
+9
New +$569 ﹤0.01% 1338

Other funds holding ACLS

CVA Family Office's ACLS Position: Q2 2026 in Review

CVA Family Office increased its Axcelis (ACLS) stake by 26% in Q2 2026, buying an estimated $742 and bringing the position to 24 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

CVA Family Office first reported a position in ACLS in Q1 2025 and has held it in 3 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • CVA Family Office held 24 shares of Axcelis worth $4.55K as of Q2 2026.
  • CVA Family Office bought 5 Axcelis shares in Q2 2026, an estimated $742.
  • Axcelis made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1300 holding.
  • CVA Family Office first reported a position in Axcelis in Q1 2025 and has held it in 3 quarters since.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.